Kathleen M Mahoney Selected Research

Immunotherapy

10/2021	Progressive immune dysfunction with advancing disease stage in renal cell carcinoma.
1/2021	VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy.
1/2020	The importance of exosomal PDL1 in tumour immune evasion.
1/2016	Learning from PD-1 Resistance: New Combination Strategies.
8/2015	Combination cancer immunotherapy and new immunomodulatory targets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen M Mahoney Research Topics

Disease

17	Neoplasms (Cancer) 10/2023 - 12/2011
7	Melanoma (Melanoma, Malignant) 01/2022 - 11/2014
5	Renal Cell Carcinoma (Grawitz Tumor) 10/2023 - 01/2016
2	Hypoxia (Hypoxemia) 10/2023 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2015 - 04/2015
2	Hodgkin Disease (Hodgkin's Disease) 04/2015 - 11/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 04/2015 - 11/2014
1	Leukemia 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Tics (Tic) 01/2019
1	Lung Neoplasms (Lung Cancer) 04/2015
1	Cardiac Tamponade 07/2013
1	Breast Neoplasms (Breast Cancer) 12/2011

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2014
5	NivolumabIBA 01/2022 - 11/2014
3	B7-H1 AntigenIBA 01/2020 - 08/2015
3	pembrolizumabIBA 12/2015 - 11/2014
2	CytokinesIBA 10/2023 - 01/2017
2	AntibodiesIBA 01/2020 - 12/2015
2	Programmed Cell Death 1 ReceptorIBA 01/2017 - 08/2015
2	IpilimumabIBA 04/2015 - 11/2014
2	atezolizumabIBA 04/2015 - 11/2014
1	Immune Checkpoint ProteinsIBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	AndrogensIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 10/2021
1	VaccinesIBA 01/2021
1	AntigensIBA 01/2021
1	temsirolimus FDA Link 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	TOR Serine-Threonine KinasesIBA 01/2016
1	Bevacizumab (Avastin)FDA Link 01/2016
1	Coloring Agents (Dyes)IBA 12/2015
1	CTLA-4 AntigenIBA 08/2015
1	Monoclonal AntibodiesIBA 04/2015
1	Immune Checkpoint InhibitorsIBA 04/2015
1	Dacarbazine (DIC)FDA LinkGeneric 04/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2015
1	LigandsIBA 11/2014
1	VemurafenibIBA 07/2013
1	Hormones (Hormone)IBA 12/2011
1	Trastuzumab (Herceptin)FDA Link 12/2011

Therapy/Procedure

9	Therapeutics 10/2023 - 12/2011
5	Immunotherapy 10/2021 - 08/2015
1	Drug Therapy (Chemotherapy) 12/2011